C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/39.1, 195/1.
C12N 15/12 (2006.01) A61K 38/37 (2006.01) C07K 14/755 (2006.01) C12N 1/00 (2006.01) C12N 5/10 (2006.01) C12N 15/63 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1341229
This invention relates to recombinant Factor VIII:c variants, methods to produce the variants and pharmaceutical compositions containing same. The variants of this invention are characterized by modification of one or more specific proteolytic cleavage sites encompassing the arginine residues at positions 220, 226, 250, 279, 282, 336, 359, 562, 740, 776, 1313, 1648, 1719 and 1721; and/or one or both of the lysine residues at positions 325 and 338 and/or serine-741. The variants possess similar or improved procoagulant activity and/or pharmacokinetic profiles compared to that of human Factor VIII:c.
538233
Kaufman Randal J.
Pittman Debra D.
Toole John J. Jr.
Genetics Institute Inc.
Genetics Institute Llc
Gowling Lafleur Henderson Llp
LandOfFree
Procoagulant proteins derived from factor viii: c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Procoagulant proteins derived from factor viii: c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Procoagulant proteins derived from factor viii: c will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1209680